A detailed history of Modus Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Modus Advisors, LLC holds 24,108 shares of ABBV stock, worth $4.83 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares
24,108
Previous 23,819 1.21%
Holding current value
$4.83 Million
Previous $4.09 Million 16.52%
% of portfolio
1.61%
Previous 1.49%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$163.84 - $199.33 $47,349 - $57,606
289 Added 1.21%
24,108 $4.76 Million
Q2 2024

Jul 02, 2024

BUY
$154.79 - $180.76 $102,161 - $119,301
660 Added 2.85%
23,819 $4.09 Million
Q1 2024

Apr 02, 2024

BUY
$159.82 - $182.1 $71,919 - $81,945
450 Added 1.98%
23,159 $4.22 Million
Q4 2023

Jan 04, 2024

BUY
$137.6 - $154.97 $67,974 - $76,555
494 Added 2.22%
22,709 $3.52 Million
Q3 2023

Oct 20, 2023

BUY
$133.59 - $154.65 $45,554 - $52,735
341 Added 1.56%
22,215 $3.31 Million
Q2 2023

Jul 05, 2023

BUY
$132.51 - $164.9 $144,700 - $180,070
1,092 Added 5.25%
21,874 $2.95 Million
Q1 2023

Apr 04, 2023

BUY
$144.61 - $166.54 $11,858 - $13,656
82 Added 0.4%
20,782 $3.31 Million
Q4 2022

Jan 05, 2023

BUY
$138.31 - $165.87 $30,981 - $37,154
224 Added 1.09%
20,700 $0
Q3 2022

Oct 05, 2022

BUY
$134.21 - $153.93 $4,026 - $4,617
30 Added 0.15%
20,476 $2.75 Million
Q2 2022

Jul 05, 2022

BUY
$137.62 - $174.96 $74,177 - $94,303
539 Added 2.71%
20,446 $3.13 Million
Q1 2022

Apr 05, 2022

BUY
$131.98 - $163.75 $9,106 - $11,298
69 Added 0.35%
19,907 $3.23 Million
Q4 2021

Jan 04, 2022

SELL
$107.43 - $135.93 $66,821 - $84,548
-622 Reduced 3.04%
19,838 $2.69 Million
Q3 2021

Oct 08, 2021

BUY
$106.4 - $120.78 $85,013 - $96,503
799 Added 4.06%
20,460 $2.21 Million
Q2 2021

Jul 01, 2021

SELL
$105.21 - $117.21 $51,237 - $57,081
-487 Reduced 2.42%
19,661 $2.21 Million
Q1 2021

Apr 05, 2021

BUY
$102.3 - $112.62 $186,697 - $205,531
1,825 Added 9.96%
20,148 $2.18 Million
Q4 2020

Jan 08, 2021

BUY
$80.49 - $108.67 $92,724 - $125,187
1,152 Added 6.71%
18,323 $1.96 Million
Q3 2020

Oct 01, 2020

BUY
$85.91 - $100.83 $377,058 - $442,542
4,389 Added 34.34%
17,171 $1.5 Million
Q2 2020

Jul 01, 2020

BUY
$73.37 - $98.18 $299,569 - $400,868
4,083 Added 46.94%
12,782 $1.26 Million
Q1 2020

Apr 08, 2020

BUY
$64.5 - $97.79 $561,085 - $850,675
8,699 New
8,699 $663,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Modus Advisors, LLC Portfolio

Follow Modus Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Modus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Modus Advisors, LLC with notifications on news.